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Abstract 
Parkinson’s disease (PD) is characterized by dopaminergic cell loss in the basal ganglia (BG) 
that causes motor impairments of speech and gait.  These symptoms may result from difficulty 
generating an internal beat (Freeman, Cody, Schady, 1993; Jahanshahi et al., 1995), with the BG 
serving as an “internal clock.”  I investigated this by administering a diagnostic task of listening 
strategy to young adults, older adults, and PD patients.  No significant differences were found 
between age/disease groups, in terms of the listening strategy recruited by participants.  However, 
trends approaching significance suggested PD patients taking dopamine agonists showed less 
accuracy on the timing task when compared to subjects taking levodopa-carbidopa, and older- 
onset PD patients had less accuracy relative to young-onset PD patients.  These findings suggest 
the BG may not play a strong role in beat perception; however, individual differences in PD 
symptoms and clinical factors, such as medications and age of disease onset, may modulate 
timing processes.   
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The Basal Ganglia and Beat Perception in Parkinson’s Disease 
Background on Parkinson’s Disease 
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, 
currently affecting approximately 10 million people worldwide (de Lau & Breteler, 2006; Morris, 
2000).  PD typically affects older adults (65-90 years of age), but young-onset PD can occur as 
early as 30-40 years of age (Lang & Lozano, 1998a; Morris, 2000).  PD is primarily 
characterized by motor symptoms, such as tremor, rigidity, difficulty starting movement 
(akinesia), slowness of movement (bradykinesia), postural instability, gait impairments, and 
monotonous, soft speech with a variable rate (dysarthia; Jankovic, 2007; Lang & Lozano, 1998a).  
Likewise, perceptual and cognitive impairments, such as loss of smell and memory impairments, 
are common in PD (Davis, 2008; Forno, 1996; Meireles & Massano, 2012).   
The motor symptoms of PD are primarily due to dopaminergic denervation (cell loss) in 
the basal ganglia (BG; Forno, 1996; Lang & Lozano, 1998a).  Initially, the dopaminergic cell 
loss is concentrated within the nigrostriatal pathway, but as the disease progresses, the cell loss 
spreads to cortical regions (Bear, Connors, Paradiso, 2007; Jones & Jahanshahi, 2009).  This 
dopamine deficiency results in an imbalance of the excitatory and inhibitory pathways in the BG, 
which ultimately leads to the disordered movement shown in PD (Lang & Lozano, 1998b).  
What triggers the dopamine loss is unknown (Bear et al., 2007; Lang & Lozano, 1998b). 
Pharmacological Treatment for PD   
The gold standard treatment of PD is levodopa-carbidopa, which is a dopamine precursor 
that directly replaces tonic dopamine levels in the brain, thus compensating for the loss of 
dopaminergic neurons in PD (Hornykiewicz, 1998).  However, other medications, such as 
dopamine agonists or COMT inhibitors, may also be used to regulate dopamine levels within the 
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brain (Rascol et al., 2003).  Dopamine agonists stimulate postsynaptic dopamine receptors, while 
COMT inhibitors slow down the metabolism of levodopa, thereby increasing the drug’s half-life 
(Bonuccelli, Dotto, & Rascol, 2009; Rascol et al., 2003).  While these medications are relatively 
effective for treating some motor symptoms of the disease, gait and speech symptoms of PD are 
relatively unresponsive to anti-parkinsonian medications (Rascol et al., 2003).       
Temporal Processing Impairments in PD 
 One hypothesis for the speech and gait impairments is that PD patients have difficulty 
internally generating and maintaining a rhythm (Freeman et al., 1993; Jahanshahi et al., 1995).  
In accord with this hypothesis, both speech and gait impairments in PD show abrupt starts and 
stops that disrupt the regularity of these rhythmic movements (Harel, Cannizzaro, Cohen, Reilly, 
Snyder, 2004; Kegl, Cohen, Poizner, 1999; Nieuwboer et al., 2001).  For example, Skodda and 
Schlegel (2008) found that PD patients had an increased speech rate, but paused less frequently 
and for a longer period of time, in comparison to age-matched controls.  Similarly, PD patients 
may show freezing of gait while walking, where the legs, arms, and eyelids suddenly stop 
moving (Jankovic, 2007).  However, studies have also shown that when PD patients speak or 
walk in synchrony with a metronome, the rhythmic impairments of speech and gait temporarily 
improve (Thaut et al., 1996; Thaut, McIntosh, McIntosh, Hoemburg, 2001).   
  To understand rhythm generation in PD, studies have investigated duration perception 
and production (temporal processing) in healthy older and young adults relative to PD patients, 
and provide evidence that PD patients have difficulty internally generating a beat (Elsinger et al., 
2003; Grahn & Brett, 2009).  However, the literature on temporal processing impairments in PD 
patients is rather mixed, with some studies reporting temporal processing deficits (Artieda, 
Pastor, Lacruz, & Obeso, 1992; Merchant, Luciana, Hooper, Majestic, Tuite, 2008; O’Boyle, 
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Freeman, & Cody, 1996; Pastor, Artieda, Jahanshahi, & Obeso, 1992) while others do not 
(Riesen & Schnider, 2001; Spencer & Ivry, 2005).     
 The mixed literature on temporal processing impairments in PD patients may be 
attributed to individual, or subgroup, differences.  Providing some support for this hypothesis, 
Merchant et al. (2008) found two types of PD patients; individuals with higher timing variability 
on the timing perception and production task, and individuals with lower timing variability when 
compared to age-matched controls.  Additionally, PD patients are heterogeneous in the 
presentation of PD symptoms, along with other clinical factors, such as age of diagnosis and 
types of PD medications used for treatment (Jankovic et al., 1990; Lewis et al., 2005; Zetusky, 
Jankovic, Pirazzolo, 1985).  The heterogeneity of PD patients, along with the mixed literature on 
impaired duration perception and production in PD, highlights the need to consider individual 
differences in temporal processing.  
Brain Regions Involved in Temporal Processing 
Animal, pharmacological, neuropsychological, and brain imaging studies have provided 
converging evidence for the involvement of a network of brain regions in temporal processing, 
including the cerebellum, prefrontal cortex, BG, supplementary motor area (SMA), and the pre-
supplementary motor area (Coull, Cheng, & Meck, 2011; Jones and Jahanshahi, 2009; Macar et 
al., 2002; Meck, 1996; Wiener, Turkeltaub, & Coslett, 2010).  The cerebellum and BG are 
thought to play a major role in temporal processing; however the specific roles of these regions 
are unclear.  Specifically, the BG are posited to serve as the “internal clock” (Coull et al., 2011; 
Grondin, 2010; Jones & Jahanshahi, 2009; Meck, 1996).  Evidence for this is shown in 
experiments with lesions to the substantia nigra pars compacta or other striatal lesions in rats, 
resulting in timing impairments (Meck 2006).  Brain imaging studies in humans have also shown 
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activation of the BG in a variety of duration perception and production tasks (Coull, Nazarian, & 
Vidal, 2008; Harrington et al., 2004; Pouthas et al., 2005) as well as activation in frontostriatal 
regions, including the SMA and prefrontal cortex (Coull et al., 2011; Macar et al., 2002).  Grahn 
and colleagues (Grahn & Brett, 2007; Grahn & Brett, 2009; Grahn & McAuley, 2009) not only 
found that both the BG and SMA were activated when young adults heard rhythmic sequences, 
but that activation intensity differed by listening strategy, where strong beat perceivers had 
greater activation of the SMA when compared to weak beat perceivers.   
Theories of Time Perception 
Two broad theoretical perspectives have been proposed to explain the internal clock used 
for beat perception and production: an interval-based or a beat-based (entrainment) perspective 
(Grondin, 2010).  The interval-based timing perspective takes an information processing 
approach to explain the internal clock, separating timing processes into three separate stages: 
clock, memory, and decision.  From this perspective, the internal clock acts as a stopwatch that 
can be started, stopped, and reset arbitrarily.  The internal clock emits pulses to match the 
duration of a time interval.  These pulses are collected in the accumulator, stored in memory, and 
used later as a referent to judge the durations of future time intervals.  Alternatively, the beat-
based perspective views the clock as an endogenous oscillator that entrains (synchronizes) to 
temporal events in the environment and generates expectancies about the occurrence of future 
events in time.   
In general, interval-based models tend to provide more accurate predictions when applied 
to timing of single durations, while beat-based models more accurately predict the timing of 
rhythmic sequences.  For example, the interval-based strategy would be better when using 
baking knowledge from previous experiences to time how long it will take for a cake to finish 
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cooking.  On the other hand, the beat-based strategy would work better when humming to a song, 
in order to keep up with the speed at a particular moment, since songs have continuous rhythmic 
sequences of time intervals.  Historically, these two perspectives on the internal clock have been 
considered competing theories; however, recent work by McAuley and colleagues (Grahn & 
McAuley, 2009; McAuley, Frater, Janke, & Miller, 2006) suggests that individuals may recruit 
either an interval- or beat-based strategy when listening to an ambiguous rhythmic sequence.  
That is, individuals vary in their propensity to rely on one type of strategy versus the other. 
Ambiguous Tempo Discrimination Task 
McAuley and colleagues (Grahn & McAuley, 2009; McAuley et al., 2006) developed an 
ambiguous tempo discrimination task to investigate individual differences in the recruitment of 
interval- or beat-based listening strategies.  For these experiments, participants heard both 
control and test tone sequences (Figure 1), in which the tempo (rate) of the sequence was marked 
by tone onsets, or the interonset intervals.  The control sequence, which is commonly used in 
studies of temporal processing, consisted of a 600 ms time interval, followed by a 1200 ms time 
interval, and a variable final time interval centered on 600 ms.  The test sequence, a modified 
version of the control sequence, consisted of two 300 ms time intervals, followed by a 1200 ms 
time interval, and a variable final time interval yoked to 600 ms.  For both the control and test 
sequences, participants judged whether the final time interval of the sequence was “speeding up” 
or “slowing down.”  The test sequence was ambiguous since it allowed individuals to judge the 
speed of the sequence using either the explicit 300 ms referents (marked by the two pairs of tone 
intervals) or the implicit 600 ms referent.  
 More beat-based individuals used the implied 600 ms referent, and judged sequences as 
“speeding up” when the final time interval was less than 600 ms, and as “slowing down” when 
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the final time interval was greater than 600 ms.  Hearing regular 600 ms time intervals 
throughout the test sequence is analogous to hearing a repetitive “beat,” and is what deems this 
strategy as beat-based.  Interval-based listeners mostly judged the sequences as “slowing down,” 
suggesting the use of the initial 300 ms referents, as the final variable time interval would always 
be greater than 300 ms.  In contrast to a beat-based strategy, the interval-based strategy either 
uses an explicitly isolated time interval or uses an average of adjacent time intervals to judge the 
end of the test sequence. Approximately 33% of the young adults were interval-based listeners, 
while 44% were beat-based listeners.  The other participants did not fit into either category 
(McAuley et al., 2006).   
 Later work by Grahn and McAuley (2009) used functional magnetic resonance imaging 
(fMRI) to test whether different brain regions were recruited based on an individual’s listening 
strategy.  All participants showed activation of areas such as the basal ganglia, cerebellum, and 
the premotor cortex.  However, strong beat perceivers had greater activation in the left SMA, left 
premotor cortex, and left insula, whereas weak beat perceivers had greater activation in the right 
premotor cortex and left posterior superior temporal gyrus.  Furthermore, differences in brain 
activation were present when individuals completed both the control and test sequences, 
suggesting that general processing differences may underlie these listening strategies. 
Current Study 
In this study, I extend the approach used by McAuley and colleagues to investigate 
performance on the ambiguous tempo discrimination task in PD patients.  PD is of specific 
interest as it is associated with dopaminergic denervation of the BG and several theories posit a 
critical role of the BG and dopamine in beat perception and production (Coull et al., 2011; 
Grondin, 2010; Jones & Jahanshahi, 2009; Meck, 1996; Wiener et al., 2010).  Previous studies 
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have shown that damage to the BG may relate to difficulties in temporal discrimination tasks 
where a beat is readily discernible (Grahn & Brett, 2007; Schwartze, Keller, Patel, & Kotz, 2011).  
In addition, recent fMRI studies using the ambiguous tempo discrimination task report 
differences in brain network activation between interval- and beat-based listeners in healthy 
individuals, yet both groups of listeners have shown activation of the BG (Grahn & McAuley, 
2009). 
In this thesis, I investigated the role of the BG in beat perception further by looking at 
individual differences in beat perception in PD patients.  I hypothesized that PD patients would 
show weaker beat perception when compared to both young and older adults, due to 
dopaminergic denervation within the BG.  If the BG plays a critical role in beat perception, PD 
patients will tend to show a more interval-based listening pattern, which would translate to 
weaker beat perception, when performing the ambiguous tempo discrimination task.  To test this 
hypothesis, I administered the ambiguous tempo discrimination task to PD patients.  I used a 
simple contrast model developed by Grahn and McAuley (2009) to quantify whether individuals 
recruited an interval- or beat-based listening strategy, called the w value.  The w value is derived 
from an individual’s proportion of “speeding up” responses for the test sequence, with values 
near 0 suggesting the use of an interval-based listening strategy, and values near 1 suggesting the 
use of a beat-based listening strategy. Since I predict PD patients to employ an interval-based 
strategy, I expect their proportion of “speeding up” responses as a function of the final time 
interval to show flatter psychometric curves, relative to older and young adult controls.  
Furthermore, I predict PD patients to have lower w values, in comparison to older and young 
adult controls, which would suggest a more interval-based listening strategy.  Support for this 
hypothesis would provide further evidence for the role of the BG in beat perception.  
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Additionally, clarifying the role of the BG in PD patients could help track the progression of the 
disease or have translational implications for speech and gait rehabilitation in PD.  
Method 
Participants 
Twenty-seven volunteers (8 female) with mild-to-moderate (Hoehn and Yahr Stage I–III; 
Hoehn & Yahr, 1967) idiopathic PD participated in return for monetary compensation.  PD 
patients ranged in age from 40 – 83 years (M = 64.95, SD = 9.04) and had an average of 6.25 
years of formal musical training (SD = 11.67).  The average number of years post-PD diagnosis 
was 7.14 (SD = 3.94).  All participants were taking anti-parkinsonian medications, such as 
levodopa-carbidopa and/or dopamine agonists, to treat their PD symptoms, and were tested while 
ON their regular medication(s).  A trained rater administered the Unified Parkinson’s Disease 
Rating Scale (Section  III-Motor) to assess motor severity (Fahn, Elton, & UPDRS Committee, 
1987).  Table 1 provides additional patient characteristics.  Patients’ data were excluded from 
analysis if they were diagnosed with any neurological or psychiatric disease other than PD, or if 
they scored below 123 (maximum raw score = 144) on the Dementia Rating Scale (DRS-2; 
Jurica, Leitten, & Mattis, 2001), which is suggestive of greater than mild cognitive impairment.  
PD patients were recruited through support groups and movement disorder clinics in 
Northwestern Ohio and Southeastern Michigan.  Seven patients were tested at Bowling Green 
State University, prior to thesis data collection.     
Control participants were 23 older adult volunteers (19 female), ranging from 54 – 87 
years of age, with an average age of 65.26 years (SD = 8.95) and 15 young adult volunteers (7 
female), ranging in age from 18 – 29 years of age, with an average age of 22.79 years (SD = 3.7) 
with no known neurological or psychiatric disorder.  Older adults had an average of 10.36 years 
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of musical experience (SD = 18.98), while young adults had an average of 2.26 years of 
experience (SD = 3.42).  Tables 2 and 3 provide additional characteristics of the older and young 
adult participants.  Collected data from older adult subjects were excluded from data analysis if 
they scored below a 123 on the DRS-2 (Jurica et al., 2001), or had any neurological or 
psychiatric disorders besides PD.  All participants received monetary compensation for their 
participation in the study.  Control participants were recruited and tested at Bowling Green State 
University as part of another research study.   
All participants signed a consent form approved by the Institutional Review Board of 
Bowling Green State University or the University of Michigan. 
Apparatus  
 Stimulus presentation and response collection were controlled with MIDILAB software 
(Todd, Boltz, & Jones, 1989) running on an IBM PC-compatible computer.  The tone sequences 
were presented binaurally, at a comfortable listening level, through Sennheiser HD 280 Pro 
headphones controlled by a Rane HC 6 headphone console and attached to a Yamaha TX81Z 
FM tone generator.  Participants responded by pressing one of two buttons on a MIDILAB 
response box.  
Stimuli 
 Figure 1 shows a schematic of the two tone sequences participants heard during the study.  
The timing of the sequences was varied by changing the duration between tone onsets or the 
interonset interval.  The control sequence consisted of four tones that marked an initial 600 ms 
time interval, followed by a 1200 ms time interval, and a variable final time interval centered on 
600 ms.  The test sequence was the same, except that it contained five tones; the additional tone 
in the test sequence subdivided the initial 600 ms time interval into two 300 ms time intervals.  
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The final time interval varied randomly from trial-to-trial and took on one of ten values yoked to 
the standard 600 ms time interval (384 ms, 432 ms, 480 ms, 528 ms, 576 ms, 624 ms, 672 ms, 
720 ms, 768 ms, or 816 ms).  This manipulation resulted in five of the control sequences 
objectively “speeding up” and five sequences “slowing down.”  Stimulus tones were 50 ms in 
duration with a fundamental frequency of 440 Hz. 
Design 
 This experiment used a 2 (sequence: control, test) x 3 (age/disease group: young adult, 
older adult, PD patient) mixed measures design.  Sequence was a within-subject variable and 
age/disease group was a between-subject variable.  
Procedure 
Prior to testing, the experimenter read instructions to the participants.  The directions 
instructed participants to judge whether the end of each sequence was “speeding up” or “slowing 
down” and emphasized that there were no right or wrong answers, and that it was acceptable to 
judge all sequences as either “slowing down,” “speeding up,” or a combination of “speeding up” 
and “slowing down.”  Participants responded by pressing one of two buttons on a response box.   
Participants completed a familiarization block to ensure they understood the task.  The 
familiarization block consisted of eight trials; both test and control sequences were presented in a 
randomized order.  Changes in the final interval were large (420 ms, 510 ms, 690 ms, and 780 
ms), so that it was easy to judge whether the control sequence was “speeding up” or “slowing 
down.” 
Five test blocks were presented.  Each test block contained 60 trials, in which control and 
test sequences were presented in a randomized order.  The order of trial blocks was 
counterbalanced between participants.  The final time interval of the sequence took on values of 
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384 ms, 432 ms, 480 ms, 528 ms, 576 ms, 624 ms, 672 ms, 720 ms, 768 ms, or 816 ms and 
varied randomly from trial-to-trial.  In total, 15 observations were obtained for each level of 
sequence and final time interval, resulting in 300 total trials.  Participants were given 4000 ms to 
respond to each sequence, and a 2500 ms intertrial interval followed participants’ responses.  
Each test block lasted approximately 10 minutes and participants received a rest break after 
completion of every two test blocks.   
  PD patients also completed two questionnaires related to their experiences with PD, 
including their perceived effectiveness of their anti-parkinsonian medications, as this can vary 
from day-to-day in patients, along with overall medication effectiveness fluctuating as the 
disease progresses (Lang & Lozano, 1998b).  I administered the Medication Effectiveness Scale 
at the beginning and end of the testing session to assess medication effectiveness and fluctuations 
during testing (Goberman, Elmer, Mackowiak, & Heaton, 2004).  For these measures, 
participants self-rated several PD symptoms, on a scale of 1-7 (1 = extreme, 7 = none), as well as 
how well they felt their PD medications were working at the moment (1 = not at all, 7 = 
perfectly).    
Data Analysis 
 The primary dependent variables were the proportion of “speeding up” responses and  w 
value, which was used to determine whether individuals recruited an interval- or beat-based 
listening strategy.  To calculate w values, the proportion of “speeding up” responses for the 10 
final time intervals of the test sequence for each participant were fit to a simple temporal contrast 
model (see Grahn and McAuley (2009) for full details) that assessed the extent to which 
participants’ temporal judgments about the test sequence were based on a 300 ms or 600 ms 
reference interval.  In this model, binary judgments (“speeding up”/“slowing down”) on a given 
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trial are assumed to be based on either a 300 ms or a 600 ms referent (P = 300 or 600, 
respectively).  The 300 ms referent correlates to the explicit time interval marked by the first 
three tones of the test sequence, whereas the 600 ms referent corresponds to an implied beat in 
the test sequence.  If individuals were more likely to use the 300 ms referent, it suggested a weak 
beat-based (interval) system, whereas using the implied 600 ms referent indicated a stronger 
beat-based system.   
For each final time interval, Ti, a temporal contrast metric, and Ci,  which measures the 
normalized difference between the final time interval and each referent (P) were calculated: 




This temporal contrast model has been shown to provide a good index of the temporal 
information participants use to make duration judgments (McAuley & Jones, 2003).  Because 
participants can use one of two possible referents, each Ti results in two values of Ci, labeled as 
Ci300 and Ci600 for the P = 300 ms and 600 ms referents, respectively.  Consistent with standard 
signal detection assumptions, temporal contrast metric values were assumed to be normally 
distributed with a standard deviation, σ (Macmillan & Creelman, 1991), and  Ci-values were z-
transformed and merged using a simple weighted average: 
z = (1 – w)zi300 + wzi600 
Finally, the combined z-score was used to predict the proportions of “speeding up” responses for 
each final time interval by using a cumulative normal distribution function: 
P(‘speeding up’) = 1 – φ(z) 
To fit the data to the model, I allowed both 𝑤 ∈ [0, 1] and σ to vary, minimizing the RMSE 
between the observed and predicted proportion of “speeding up” responses.  
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 Importantly, the w value indicated whether an individual recruited an interval- or beat-based 
listening strategy for the test sequence, based on whether their duration judgments relied upon 
the explicit 300 ms or the implicit 600 ms referent.  W values ranged on a continuous scale from 
0 to 1, with values closer to 0 suggesting the recruitment of an interval-based listening strategy 
and values closer to 1 suggesting a more beat-based listening strategy.   
To classify participants as using either an interval- or beat-based listening strategy, I 
performed a median split on w values within each age/disease group.1  Additionally, to analyze 
PD medication effects on beat perception, participants were classified into three categories: those 
taking only levodopa-carbidopa, levodopa-carbidopa and a dopamine agonist, or only taking 
dopamine agonist(s).  
A total of four older adults, one young adult, and six PD patients were removed from the 
final analyses due to either failure to follow task instructions or inattention during the experiment; 
in all cases, just-noticeable difference (JND) thresholds could not be calculated or were greater 
than two standard deviations above the mean.  Data analysis was performed on 14 young adults, 
19 older adults, and 21 PD patients; I tested 14 PD patients for the thesis project.   
All statistical analyses were performed using SPSS version 19 for windows (SPSS, 2010) 
using an alpha level of 0.05.  In cases where the assumption of sphericity was violated, the F- 
statistic was evaluated for significance using the Greenhouse-Geisser adjusted degrees of 
freedom for all ANOVA analyses.    
Results 
Research has shown general duration discrimination impairments in PD patients, relative 
to age-matched controls, as well as between older and young adults (Artieda et al., 1992; Grahn 
& Brett, 2009; Merchant et al., 2008).  I performed a preliminary analysis on JNDs for the 
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control sequence to assess potential differences in duration discrimination thresholds between the 
age/disease groups.   JNDs for the age/disease groups were submitted to a one-way ANOVA for 
independent measures, and were found to differ between the age/disease groups, F(2, 53) = 3.61, 
p = .03.  Post hoc Tukey HSD tests revealed that PD patients had significantly higher JNDs, or 
worse discrimination thresholds (M = 17.62, SE = 6.68) than young adults (M = 12.51, SE = 
2.09), but patients’ JNDs did not differ relative to older adult controls (M = 16.71, SE = 6.30), p 
= .03 and p = .87.  Older adults also had higher JNDs when compared to young adults; this 
trended towards significance, p = .10.  Due to differences in JNDs between the age/disease 
groups, JNDs were used as a covariate in our analyses. 
In order to quantify whether individuals recruited more of an interval- or beat-based 
listening strategy, studies have looked at the proportion of “speeding up” responses.  McAuley 
and colleagues (Grahn & McAuley, 2009; McAuley et al., 2006) found that, when looking at the 
proportion of “speeding up” responses as a function of the final time interval, young adults had 
different psychometric curves for the test sequence, depending on their listening strategy.  Figure 
2 shows the average proportion of “speeding up” responses as a function of the final time 
interval for both the control and test sequences for young adults, older adults, and PD patients.  
Most participants judged the control sequence as “speeding up” when the final time interval was 
greater than 600 ms, and “slowing down” when the final time interval was less than 600 ms, 
resulting in an S-shaped curve that is frequently observed for this type of sequence.   Though 
participants in all three age/disease groups performed similarly, the psychometric curves tended 
to vary more around 552 ms to 696 ms in the control sequence (Figure 2a).  Furthermore, both 
interval- and beat-based listeners from all three age/disease groups had S-shaped curves.    
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In contrast to the control sequence, participants across all three age/disease groups 
showed a split in responses for the test sequence based on their listening strategy.  Beat-based 
listeners judged the sequence as “speeding up” when the final time interval was less than 600 ms, 
and “slowing down” when the final time interval was greater than 600 ms, showing a similar 
pattern of responses to the control sequence.  However, interval-based listeners, on average, also 
judged the sequence as “speeding up” when the final time interval was less than 600 ms, but their 
curves flattened out into horizontal lines, meaning that many interval-based listeners judged the 
sequences as “slowing down” more often than participants who had recruited a beat-based 
strategy.   
A 2 (sequence: control, test) x 2 (listening strategy: beat-based, interval-based) x 3 
(age/disease group: young adult, older adult, PD patient) x 10 (final time interval: 384 ms, 432 
ms, 480 ms, 528 ms, 576 ms, 624 ms, 672 ms, 720 ms, 768 ms, and 816 ms) mixed measures 
ANOVA on the proportion of “speeding up” responses was conducted to assess differences 
across age/disease groups in listening strategy.  Based on my primary hypothesis, I predicted PD 
patients would show flatter or more curvilinear shaped lines relative to young and older adult 
controls, regardless of listening strategy, which would support my hypothesis of weaker beat 
perception in PD patients.  Contrary to my hypothesis, the critical four-way interaction between 
sequence, listening strategy, age/disease group, and final time interval was not significant, 
F(7.61, 178.93) = 0.24, p = .98.  Moreover, I did not find an effect of group, suggesting that 
young adults, older adults, and PD patients did not differ from each other on their proportions of 
“speeding up” responses for the control and test sequences, F(2, 47) = 1.25, p = .30.   
The mixed measures ANOVA revealed several interactions, including a three-way 
interaction between sequence, final time interval, and listening strategy, listening strategy and 
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sequence, final time interval and listening strategy, and final time interval and sequence.  The 
three-way interaction between  sequence, final time interval, and listening strategy showed that 
listening strategy had a greater effect for the final time intervals in the test sequence, as beat-
based listeners had significantly higher average “speeding up” responses relative to interval-
based listeners, F(3.81, 178.93) = 12.26, p < .001.  A two-way interaction between listening 
strategy and sequence revealed that beat-based listeners had higher average proportions of 
“speeding up” responses for the control (M = 0.47, SE = 0.02) and test (M = 0.41, SE = 0.02) 
sequences, when compared to interval-based listeners for the control (M = 0.48, SE = 0.02) and 
test sequences (M = 0.17, SE = 0.02), F(1, 47) = 28.74, p < .001.  Another interaction between 
final time interval and listening strategy displayed that beat-based listeners also had higher mean 
proportions of “speeding up” responses across the 10 final time intervals compared to interval-
based listeners, F(3.99, 187.39) = 8.39, p < .001.  Additionally, an interaction between final time 
interval and sequence revealed that the mean proportions of “speeding up” responses were higher 
for the final time intervals in the control sequence relative to the test sequence, F(3.81, 178.93) = 
13.09, p < .001.   
Finally, I found several main effects including effects of sequence, final time interval, 
and listening strategy.  The mean proportion of “speeding up” responses was higher for the 
control sequence (M = 0.47, SD = 0.02) relative to the test sequence (M = 0.29, SD = 0.01), F(1, 
47) = 14.93, p < .001.  Similarly, the mean proportion of “speeding up” responses was higher 
when the final time intervals were less than 600 ms, when compared to the mean proportion of 
“speeding up” responses for the final time intervals that were greater than 600 ms, F(3.99, 
187.39) = 132.03, p < .001.  The mean proportion of “speeding up” responses was also higher 
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when individuals were beat-based listeners (M = 0.44, SD = 0.01) when compared to interval-
based listeners (M = 0.32, SD = 0.01), F(1, 47) = 30.28, p < .001.   
The same analysis was performed on the proportion of “speeding up” responses, except 
that a median split on w values was created for all participants in the three age/disease groups, to 
assess individual differences in the listening strategy between groups.  This analysis revealed the 
same pattern of results.  
Another way to study differences in perception based on listening strategy is to look at 
the w value.  To assess the effects of sequence-type between age/disease groups, I performed a 2 
(sequence: control, test) x 3 (age/disease group: young adult, older adult, PD patient) mixed 
measures ANOVA on w values.  Figure 3 shows the average w values as a function of 
age/disease group and sequence.  For both control and test sequences, all three age/disease 
groups had similar w values.  Based on my hypothesis that PD patients would be less likely to 
use a beat-based listening strategy, I predicted PD patients to have lower w values relative to 
older and young adult controls, for the test sequence.  However, I did not find support for this 
hypothesis.  No significant interactions nor main effects were found (ps > .14). 
 Few studies have looked at individual differences in w values, rather than looking at 
group averages (Grahn & McAuley, 2009; Snyder, Pasinski, & McAuley, 2011).  Figure 4 shows 
each participants’ w values as a function of age/disease group on the test sequence.  Older adults 
and PD patients show greater dispersal in w values when compared to young adults, though, all 
three age/disease groups show a clustering toward w values closer to 1, suggesting that the group 
means in w values are fairly representative of the data.   
 A number of metrics also exhibited widely varying scores within the PD patient group, 
including musical experience, age of diagnosis, and anti-parkinsonian medications that 
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participants were taking during the testing session.  I performed several follow-up analyses to 
assess whether these factors affected engagement of either an interval- or beat-based listening 
strategy.   
Previous studies have considered whether years of musical experience affect beat 
perception strength and found no correlation between the two (Grahn, Henry, & McAuley, 2011; 
Grahn & McAuley, 2009).    Years of musical experience included total number of years in 
dance, voice, and instrumental training.  I conducted a bivariate Pearson correlation on all 
participants and also found no significant correlation between years of musical experience and w 
values, r(19) = -0.28, p = .22.  Similarly, the total number of hours spent listening to music was 
not significantly correlated to w values, r(19) = -0.27, p = .24.  On the other hand, a chi-square 
analysis revealed that there were differences in the distribution of gender among the age/disease 
groups, x2(2, 55) = 14.603, p < .001.  The PD patients included in the final data analysis 
consisted of more males (n = 16) than females (n = 5), while in the older adult control group 
there were more females (n = 16) than males (n = 3).  
A recent study by Diederich, Moore, Leurgans, Chmura, & Goetz (2003) found that PD 
patients with older age of disease onset have greater motor impairment when compared to 
younger-onset PD patients.  To address whether age of PD onset affected beat perception, I split 
the PD patients by those who were diagnosed before or at age 60 and those diagnosed at age 61 
or older.  I conducted a  2 (sequence: control, test) x 2 (age of diagnosis: under 60, 61 and older) 
x 2 (listening strategy: interval-based, beat-based) x 10 (final time interval: 384 ms, 432 ms, 480 
ms, 528 ms, 576 ms, 624 ms, 672 ms, 720 ms, 768 ms, and 816 ms) mixed measures ANOVA on 
the proportion of “speeding up” responses to analyze the effect of age of diagnosis.  Sequence 
and final time interval were within-subject factors, while age of diagnosis and listening strategy 
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were the between-subject factors.  The split around age 60 was created because I had a smaller 
sample size of patients with a smaller age of disease onset range, and this grouping was similar 
to the split used by Diederich et al. (2003).  
No significant four-way interaction was found between sequence, age of diagnosis, 
listening strategy, and final time interval, F(3.87, 61.98) = 1.42, p = .24.  Moreover, no effect 
was found for age of diagnosis, suggesting that proportion of “speeding up” responses did not 
differ between patients diagnosed before or at 60 years of age when compared to patients 
diagnosed at age 61 years or older, F(1, 16) = 2.58, p = .13.  However, a trending interaction 
between sequence, listening strategy, and age of diagnosis was found where people diagnosed 
with PD at or under the age of 60, who used a beat-based listening strategy, had higher mean 
proportion of “speeding up” responses (M = 0.50, SE = 0.04) on the test sequence, relative to 
patients with older age of disease onset (M = 0.36, SE = 0.04), F(1, 16) = 3.24, p = .09.  There 
was another trend towards a two-way interaction between listening strategy and age of diagnosis, 
where young-onset PD patients who recruited a beat-based listening strategy had overall higher 
mean proportion of “speeding up” responses relative to other young- and older-onset PD patients 
using other listening strategies, F(1, 16) = 2.82, p = .11.  Here, patients with young-onset PD, 
who used a beat-based listening strategy, had a higher mean proportion of “speeding up” 
responses (M = 0.49, SE = 0.03) when compared to beat-based older-onset PD patients (M = 0.38, 
SE = 0.03), interval-based older-onset PD patients (M = 0.34, SE = 0.05), and interval-based 
young-onset PD patients (M = 0.34, SE = 0.02).  In addition, a 2(sequence: control, test) x 2(age 
of diagnosis: under 60, 61 and older) mixed measures ANOVA on w values showed neither 
significant interactions nor main effects (ps > .24).  Age of diagnosis was analyzed further by 
conducting a bivariate Pearson correlation on age of diagnosis and JNDs of the age/disease 
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groups on the control sequence, showing no significance, r(19) = -0.05, p = .82.   Similarly, 
Pearson correlations looking at age of diagnosis and w values for both the control, r(19) = 0.17, p 
= .46, and test sequences, r(19) = -0.08, p = .74, failed to reach significance.  
Another follow-up ANOVA was created to observe whether the class of PD medications 
that participants took affected beat perception.  Many PD patients vary in the types of 
medications they take to control their motor symptoms, and levodopa-carbidopa or dopamine 
agonists are often used to treat symptoms.  In my sample, patients were taking only levodopa-
carbidopa (n = 8), a combination of levodopa-carbidopa and dopamine agonists (n = 8), or solely 
dopamine agonists (n = 5).  I performed a 2 (sequence: control, test) x 2 (listening strategy: 
interval-based, beat-based) x 3 (medication class: levodopa-carbidopa, levodopa-carbidopa and 
dopamine agonist, dopamine agonist) x 10 (final time interval: 384 ms, 432 ms, 480 ms, 528 ms, 
576 ms, 624 ms, 672 ms, 720 ms, 768 ms, and 816 ms) mixed measures ANOVA on the 
proportion of “speeding up” responses.  Sequence and final time interval were within subject 
factors, while listening strategy and medication class were between subject factors.  No 
significant four-way interaction was found between sequence, class of PD medications, listening 
strategy, and final time interval, F(6.63, 46.43) = 0.60, p = .74.  In addition, there was no 
significant effect for class of PD medications suggesting that the mean proportion of “speeding 
up” responses did not differ between individuals only taking levodopa-carbidopa, those taking 
both levodopa-carbidopa and a dopamine agonist, and people taking only dopamine agonists, F(2, 
14) = 0.39, p = .68.   
However, the ANOVA revealed a trend towards a three-way interaction between 
sequence, class of PD medication, and listening strategy, where patients using an interval-based 
listening strategy and also taking dopamine agonists had lower mean proportion of “speeding up” 
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response relative to patients taking other drugs and using either a beat-based or interval-based 
listening strategy, F(2, 14) = 2.62, p = .10.  Patients who used an interval-based listening strategy 
and were on dopamine agonists had the lowest mean proportion of “speeding up” responses on 
the test sequence (M = 0.047, SE = 0.01) relative to patients who recruited an interval-based 
listening strategy and were on a combination of levodopa-carbidopa and dopamine agonists (M = 
0.19, SE = 0.06), or solely taking levodopa-carbidopa (M = 0.23, SE = 0.05), as well as patients 
using a beat-based listening strategy who were solely on dopamine agonists (M = 0.53, SE = 
0.07), a mixture of the two medication types (M = 0.45, SE = 0.48), or only on levodopa-
carbidopa (M = 0.39, SE = 0.06).    I also conducted a 2 (sequence: control, test) x 3 (medication 
class: levodopa-carbidopa, levodopa-carbidopa and dopamine agonist, dopamine agonist) mixed 
measures ANOVA on w values.   No significant interactions or main effects were found between 
sequence and class of PD medications (ps > .32).  
Discussion 
 The aim of this experiment was to test whether the basal ganglia (BG) plays a role in beat 
perception.  To address this issue, I looked at the performance of young adults, older adults, and 
PD patients on an ambiguous tempo discrimination task to determine whether PD patients were 
more likely to recruit a different listening strategy relative to controls.  Due to dopaminergic 
denervation of the BG in PD, I hypothesized that PD patients would have weaker beat perception, 
and use a more interval-based listening strategy, relative to young and older adult controls.  
Specifically, I predicted that PD patients would have both flatter psychometric curves when 
looking at the proportion of “speeding up” responses as a function of the final time interval, and 
have lower w values compared to young and older adults. 
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 Contrary to my hypothesis no differences in either the proportion of “speeding up” 
responses or w values were found between young adults, older adults, and PD patients meaning 
that listening strategy, and consequently, beat perception, did not differ between these groups.  
However, I did find a difference in discrimination thresholds between PD patients and young 
adults where PD patients had higher JNDs when compared to young adult controls.  Within the 
PD group, there was a trend towards an interaction where patients using an interval-based 
listening strategy and solely on dopamine agonists performed the timing task with less accuracy, 
and had lower mean “speeding up” responses relative to patients on levodopa-carbidopa or a 
mixture of levodopa-carbidopa and dopamine agonists. Furthermore, another trend suggested 
that PD patients with a younger age of disease onset performed the task with greater accuracy, 
having higher mean “speeding up” responses for the 10 final time intervals, in comparison to 
patients with an older age of disease onset. 
 My finding that the age/disease groups did not differ on beat perception strength was 
surprising since previous animal, neuropsychological, pharmacological, and brain imaging 
studies have posited a strong role for the BG and dopamine in rhythmic temporal processing 
(Jones & Jahanshahi, 2009; Meck, 2006; Coull et al., 2008; Pouthas et al., 2005; Harrington et al., 
2004; Grahn & McAuley, 2009; Grahn & Brett, 2007; Grahn & Brett, 2009; Wiener et al., 2010; 
Coull et al., 2011; Ferrandez et al., 2003).  The initial PD patient data supported the hypothesis 
of lower w values in PD patients relative to controls; however after adding the University of 
Michigan PD sample, this trend disappeared.   
One potential explanation for this unexpected result between the Bowling Green and 
Michigan patient samples was the range of musical experience.  Out of the 14 PD patients tested 
in Michigan, only two patients had no musical experience, compared to the nine PD patients 
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without musical experience in the Bowling Green patient sample.  However, I did not find a 
significant correlation between w values and years of musical training, which argues against this 
potential explanation.  This finding is supported by Grahn and McAuley (2009) who also found 
no correlation between w values and musical training when administering the same timing task to 
healthy young adults.   
  My results do not support previous work suggesting that rhythm perception is impaired 
in PD patients (Grahn & Brett, 2009).  An explanation of these conflicting findings may be that 
Grahn and Brett had a more complex timing task that required greater cognitive demand from 
PD patients.  Their duration discrimination task required participants to listen to three sequences 
and judge whether the third sequence was the same or different from the previous two sequences.  
In contrast, the duration discrimination task I administered only required participants to listen to 
a single sequence and judge whether the end of the sequence was “speeding up” or “slowing 
down.”  This task has been shown to separate strong and weak beat listeners (Grahn & McAuley, 
2006; Grahn & McAuley, 2009; Snyder et al., 2011) among healthy young adults, but may not be 
sensitive to beat perception differences between age/disease groups.   
Another potential explanation for my conflicting results may be the difference in 
demographics of the PD patients I had tested in comparison to the sample tested in the Grahn and 
Brett (2009) study.  Not only did their study test a smaller sample size of PD patients, but they 
looked at patients across a smaller age range (57 – 80 years) in comparison to my experiment.  
Thus, the trend in lower w values may also potentially disappear with more subjects and a wider 
variety of young and older PD patients.   
I cannot rule out the possibility that there may be compensatory mechanisms from other 
brain regions involved in beat perception, since besides the BG there has been activation of the 
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SMA, premotor cortex, superior frontal gyri, and inferior frontal gyrus on duration perception 
and production tasks (Grahn & Brett, 2007; Grahn & McAuley, 2009).  It may be plausible that 
even without a fully functional BG, some of these cortical areas can execute the neural actions of 
the BG in beat perception, to an extent.  However, this reasoning is unlikely because, if 
compensatory mechanisms are present for beat perception, there would be no significant 
difference in beat perception in the Grahn and Brett (2009) study between PD patients and 
healthy older adults.      
 I did find a difference between discrimination thresholds between PD patients and 
healthy young adults, where PD patients had higher JNDs on the control sequence relative to 
young adult controls.  Additionally, the data showed a trend for older adults having higher JNDs 
when compared to young adults.  Because both PD patients and older adults had higher JNDs 
when compared to young adults, but older adults and PD patients did not differ significantly 
from each other, this may reflect an age-related impairment, rather than one strictly associated 
with PD.  This finding is consistent with the results of Fitzgibbon and Gordon-Salant (1995), 
who had found differences in discrimination thresholds by age, where older adults had higher 
discrimination thresholds when listening to isolated time intervals of tones with varying 
frequencies, compared to young adults.  The study looked at the performance of both older and 
young adults with and without hearing loss, and found no significant effects of hearing loss.  
Thus, the PD patients and older adults in my experimental sample may have hearing deficits due 
to aging, though participants were administered a hearing screening during the testing session. 
   Interestingly, a trend towards a three-way interaction between sequence, listening 
strategy, and class of PD medication was found where patients taking dopamine agonists, who 
also used an interval-based listening strategy had lower mean “speeding up” responses relative to 
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patients, using an interval- or beat-based approach, taking levodopa-carbidopa or a combination 
of the therapies, suggesting that medication type can potentially affect temporal perception.  
Research has shown that PD patients taking dopamine agonists may become more impulsive, or 
prone to risk-taking behaviors (Claassen et al., 2011; Voon et al., 2011; Weintraub et al., 2006; 
Weintraub et al., 2010).  Weintraub et al. (2010) found that PD patients taking dopamine 
agonists had a two to three times increased chance in developing impulse control disorders.  
However, the effect of dopamine agonists on risk-taking behaviors seems to be greater when PD 
patients are diagnosed with impulse control disorder or show symptoms of it, prior to taking 
dopamine agonist therapy.  Furthermore, impulsivity has shown to affect time perception, 
specifically, by speeding up the “internal clock.”  Barratt (1981) studied adolescent psychiatric 
patients diagnosed as extremely aggressive and adolescent controls on a duration production task.  
He found that the patients with higher scores on an impulsivity survey under-reproduced time 
intervals relative to adolescent controls, suggesting that impulsivity can affect an individual’s 
sense of time.   
In the current study, PD patients on dopamine agonists may be exhibiting side effects of 
the medication with an increase in impulsivity resulting in a speeding up of the “internal clock.” 
Consistent with this explanation, even though it did not reach statistical significance, PD patients 
taking dopamine agonists had lower w values for the test sequence, in comparison to patients 
taking levodopa-carbidopa or a combination of the drug therapies.  However, when looking at 
the proportion of “speeding up” responses as a function of the final time interval, patients 
categorized in each class of PD medication showed similar S-shaped functions.  Since there were 
no significant interactions between class of PD medication and final time interval, I cannot say 
with certainty whether PD patients judged most of the sequences as “speeding up” or “slowing 
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down.”  A limitation to this analysis was that we did not administer a survey of impulsivity to the 
PD patients.   
Another factor within the PD group was age of diagnosis.  I found a trend where patients 
diagnosed below or at the age of 60, who also recruited a beat-based listening strategy, had 
higher mean proportion of “speeding up” responses on the test sequence, relative to patients 
diagnosed older than 60 years who also used a beat-based listening strategy.  Moreover, a trend 
displayed that patients with young-onset PD and a beat-based listening strategy had higher mean 
proportion of “speeding up” responses in comparison to all patients with older-onset PD as well 
as young-onset PD patients using an interval-based listening strategy.  However, when looking 
only at patients using an interval-based listening strategy, young- and older-onset PD patients 
had almost the same mean proportion of “speeding up” responses, suggesting a potential decline 
with age, in the ability to use a beat-based listening, but not an interval-based listening strategy.  
Since the ANOVA failed to reveal any significant interactions between age of diagnosis and final 
time interval, it is difficult to say with certainty how the “speeding up” responses varied with the 
final variable time intervals, though looking at the proportion of “speeding up” responses as a 
function of the final time interval, both young- and older-onset PD patients showed similar S-
shaped curves.  However, as the final time intervals changed to smaller percentage differences 
which were still less than 600 ms, the older-onset PD curve dropped off more quickly, hinting 
that more of the older PD patients failed to recognize those final intervals as “speeding up.”    
A study by Diederich et al. (2003) found that age of disease onset does result in 
differences in both motor impairment and PD treatment.  Individuals with older age of disease 
onset (78 years of age or older) had significantly higher UPDRS scores, specifically for rigidity, 
bradykinesia, and axial impairments (which include gait and postural instability) in comparison 
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to those with younger age of disease onset (43 – 66 years).  Older-onset PD patients were also 
more likely to receive levodopa-carbidopa treatment rather than dopamine agonists.  My results 
suggest a potential perceptual difference associated with age of disease onset that may also show 
through axial impairments, and support Diederich et al.’s (2003) association between age of 
disease onset and medication treatment.  For instance, the trending difference in average 
proportion of “speeding up” responses between young- and older-onset PD patients may be 
associated with the greater motor difficulty older-onset PD patients have in gait, as this has been 
hypothesized to be a potential rhythmic impairment (Nieuwboer et al., 2001; Thaut et al., 1996).    
All PD participants scored above 123 on the Dementia Rating Scale-2 so the perceptual 
difference was not related to a cognitive impairment within the PD group.  Supporting Diederich 
et al. (2003), in the current study, patients diagnosed before or at 60 years of age were taking 
dopamine agonist therapies, while only one PD patient diagnosed above the age of 60 was taking 
a combination of dopamine agonists and levodopa-carbidopa therapies.            
Research has shown that usually, young-onset PD patients are given dopamine agonists 
(Diederich et al., 2003; Kostic, 2009) as treatment to delay the usage of levodopa-carbidopa, 
which is a direct dopamine replacement therapy.  The reason for this is that levodopa-carbidopa 
is associated with motor complications, such as dyskinesia (Antonini, Tolosa, Mizuno, 
Yamamoto, & Poewe, 2009), and using the medication over a longer period of time results in a 
shorter duration of effectiveness (also called the “honeymoon effect”) where after the first couple 
of years, the drug has a “wearing off” effect that can last from minutes to hours (Lang & Lozano, 
1998b).  Furthermore, young-onset PD patients using levodopa-carbidopa as their primary 
treatment can have an earlier appearance of levodopa-induced dyskinesia (Kostic, 2009).  
However, most PD patients are put on levodopa therapy eventually, and end up suffering from 
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PD motor complications at the same rate as PD patients initially taking levodopa-carbidopa 
(Kostic, 2009).  Although dopamine agonists can delay levodopa usage in young-onset PD 
patients, the results of my study suggest that, beyond side-effects of hypersomnia, hallucinations, 
and impulse control disorders, there may be effects on beat perception.      
Limitations 
 In addition to the limitations already discussed, this study tested two samples of PD 
patients from two cohorts within Ohio and Michigan.  Sampling from the two recruitment 
regions may have resulted in different PD treatment by physicians and therapists.  Also, few 
patients with young-onset PD were tested, thus not providing a complete picture of the 
perceptual abilities of the PD population.  PD patients were only tested ON their PD medications, 
thus potential differences in beat perception between age/disease groups may have been obscured 
by the replacement of tonic levels of dopamine in the BG through medications.  Additionally, 
specific PD medication dosage information was not obtained from all 21 PD patients; only 14 
patients provided us with details of medication dosages, therefore precluding calculation of the 
levodopa equivalent dosage and its potential effects on beat perception and production.  
Furthermore, the older adult controls were mostly female, while the PD patients tested in the 
study were mostly male, so the lack of perceptual differences may have resulted from different 
distributions of gender in the three age/disease groups.  Another limitation was that only PD 
patients diagnosed before or at 60 years of age were on dopamine agonists, while only one 
patient over 60 years of age was taking levodopa-carbidopa with a dopamine agonist.  Also, the 
small sample size of PD patients on these medications resulted in a large standard error in the 
average w value of PD patients only on dopamine agonists.      
Conclusion and Future Studies 
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The current findings suggest that although beat perception did not differ between the 
age/disease groups, there were factors within the PD group, such as class of PD medication and 
age of diagnosis that might affect beat perception.  Though no evidence was found for significant 
differences in beat perception, follow-up studies should replicate the ambiguous tempo 
discrimination experiment and observe the performances of a larger PD patient sample, both ON 
and OFF their anti-parkinsonian medications, from various areas in the U.S.   
In the future, it may also be of interest to study beat perception by class of PD medication 
using a larger sample size of PD participants with more PD patients with an older age of disease 
onset who are on dopamine agonists, to see if dopamine agonists do speed up the internal clock.  
Likewise, dosage information should be taken into account to see if the effects of dopamine 
agonists on beat perception vary by higher or lower medication doses.  Furthermore, the 
interaction between age of diagnosis and PD treatment should be studied, as previous research 
has shown that PD patients with a younger age of disease onset are more prone to receiving 
dopamine agonist treatment.  It is unknown how young- and older-onset PD patients react to 
various anti-parkinsonian medications and how these medications might affect their beat 
perception strengths.  Studies should also explore the specific effects of impulsivity on beat 
perception, by looking at PD patients with impulse control disorders, as approximately 13.6% of 
PD patients display impulse control disorders (Weintraub et al., 2010).  This can greatly affect 
their lives as it induces gambling, excessive shopping, hypersexuality, and compulsive eating 
(Weintraub et al., 2010).  If dopamine agonist treatment increases the risk of developing 
impulsivity, physicians should be sensitive to individual differences in clinical symptoms of PD, 
including impulsiveness, so as not to prescribe PD medications which may exacerbate the current 
PD symptoms or give rise to new symptoms.  
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In conclusion, the current study primarily suggests that the BG does not play a major role 
in beat perception and, perhaps, physicians and physical therapists should have greater sensitivity 
to individual differences in PD symptoms and clinical factors, to increase the effectiveness of PD 
treatment through medication and physical rehabilitation.      
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Footnotes 
1Since each age/disease group had a different range of w values, I performed a median split on w 
values to accurately assess if each individual was more of an interval- or beat-based listener 
relative to other individuals in their age/disease group.  Young adults (n = 14), were split on a w 
value of 0.81, older adults (n = 19) were split on a w value of 0.66, and PD patients (n = 21) were 
split on a w value of 0.80.  Beat-based listeners had w values above and interval-based listeners 
had w values below the respective median values.  Participants who fell on the median value 
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Table 1  
PD Patient Characteristics 











1 60 M 3.5 143 16 10 3 5, 8, 11 --- 
2 62 M 1.5 138 16 8 0 5, 6, 7 --- 
3 67 M 3 140 12 19 0 1, 3, 7 --- 
4 64 M 4 139 16 18 0 4, 6, 12 --- 
5 61 M 10 137 12 18 0 1, 5, 6 --- 
6 70 F 10 142 12 7 0 5, 6, 8 --- 
7 77 M 13 126 16 36 4 1, 3 --- 
8 66 M 3 142 16 14 0 1, 3, 6 --- 
11 40 F 4 142 13 10 0 1, 3, 6 --- 
12 60 M 3 140 16 17 50 1, 3, 5, 6, 7, 9 --- 
13 76 F 7 138 18 18 0 1 --- 
14 57 F 9 135 12 22 5 10 450 
15 63 M 10 138 19 12 0 1, 5, 6, 8 280.5 
17 65 F 5 141 16 22 13 1, 10 901.5 
18 63 M 5 136 16 29 7 1, 6, 7 120 
19 69 M 16 143 22 29 4.25 3, 11 100.375 
21 66 M 12 141 16 33 5 2 264 
23 83 M 8 140 16 32 2 1 1.5 
25 73 M 11 143 23 29 17 1, 10 202.25 
26 69 M 5 142 17 15 21 1 0.5 
27 53 M 7 132 14 32 0 1 0.5 
Mean 64.95  7.14 138.95 15.90 20.48 6.25  218.99 
SD 9.04  3.94 4.15 2.96 9.0 11.67  278.34 
Note. Participant characteristics for the 21 PD patients whose data were used in the study; the six patients whose data analyses were excluded are not shown in 
this table.  SD = standard deviation; DRS-2 = Dementia Rating Scale (2nd edition); UPDRS-Motor = Unified Parkinson’s Disease Rating Scale-motor 
examination; LED = Levodopa Equivalence Dose, measure of PD medications standardized to the effect of 100 mg of levodopa (Tomlinson et al., 2010).  
*Medication dosage was not collected for participants 1-13.  1 = levodopa-carbidopa (regular); 2 = levodopa-carbidopa and entacapone (Stalevo); 3 = levodopa-
carbidopa controlled release (CR); 4 = ropinirole (Requip); 5 = ropinirole-extended release (Requip XL); 6 = rasagiline (Azilect); 7 = clonazepam; 8 = 
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Table 2  
Older Adult Characteristics 
Participant Age Sex DRS-2 Years of Musical Training 
1 54 M --- 0 
2 60 F --- 0 
3 56 F --- 9 
5 68 F --- 3 
7 63 F --- 16 
9 87 F --- 3 
10 67 F 141 50 
11 69 M 139 3 
12 57 F 142 19 
14 69 F 138 1.08 
15 74 F 144 7 
16 62 F 141 0 
17 60 F 138 7 
18 60 F 143 72 
19 61 F 143 2 
20 78 F 142 .75 
23 58 M 142 0 
24 58 F 141 1 
25 79 F 133 3 
Mean 65.26  140.54 10.36 
SD 8.95  2.93 18.98 
Note. Participant characteristics for the 19 older adults whose data were used in the study; the four 
participants whose data analyses were excluded are not shown in this table.  SD = standard deviation; DRS-
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Table 3  
Young Adult Characteristics 
Participant Age Sex Years of Musical Training 
2 21 F 0 
3 20 F 0 
4 28 M 0 
5 24 F 7 
6 28 M .08 
8 21 F 8.50 
9 18 F 0 
11 21 M 0 
14 29 F 7 
18 21 M 0 
19 20 M 0 
20 27 F 0 
21 19 M 2 
22 22 M 7 
Mean 22.79  2.26 
SD 3.70  3.42 
Note. Participant characteristics for the 14 young adults whose data were used in the study; the one 
























Figure 1.  Schematic of three tone sequences.  A. An equally-timed (isochronous) 
sequence of three 600 ms time intervals and a final 500 ms (shortened) time interval.  
This sequence is included for reference; this sequence was not presented to participants.  
B. The test sequence was delineated by two 300 ms time intervals followed by a 1200 ms 
time interval, and a final variable time interval centered on 600 ms.  C. The control 
sequence was delineated by a 600 ms time interval, a 1200 ms time interval, and a 
variable final interval centered on 600 ms.  Participants judged whether the end of each 
sequence, both control and test, was “speeding up” or “slowing down.” 
A.   
 
    600 ms              1200 ms      600 ± ∆T ms    
B.  Test Sequence 
300 ms 300 ms     1200 ms          600 ± ∆T ms 
600 ms     600 ms    600 ms  500 ms 
C.  Control Sequence 
 











Figure 2.  The mean proportion of “speeding up” responses as a function of listening strategy and age/disease group for the 10 final 
time intervals.  Listening strategy was determined by performing a median split on w values within each age/disease group.  
Individuals with w values above the median were labeled as “beat-based” listeners, and those with w values equal to or below the 
median were labeled as “interval-based” listeners.  A. Young adults (YA), older adult controls (OA) and PD patients had a similar 
pattern of “speeding up” responses for the control sequence; however, the proportion of “speeding up” responses varied between 
interval and beat-based listeners from 552 ms to 696 ms.  B. No differences were found in the proportion of “speeding up” responses 
between the age/disease groups and the proportion of participants that fell into the two listening strategies were relatively equal.  
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However, paralleling previous studies, differences in the pattern of “speeding up” responses differed between beat- and interval-based 
listeners.  Beat-based listeners have a S-shaped curve, suggesting that they judge the test sequence to be “speeding up” when the final 
interval is less than 600 ms, and “slowing down” when the final interval is greater than 600 ms.  Interval-based listeners show more 
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Figure 3.  Mean w values as a function of age/disease group and sequence.  W values are bound 
between 0-1, with values closer to 0 suggesting the use of an interval-based listening strategy and 
values closer to 1 indicating a beat-based listening strategy.  Similar w values were found for 
both the control and test sequences between the age/disease groups. 
 
BASAL GANGLIA AND BEAT PERCEPTION                                                             51 
 
 
Figure 4.  Boxplot showing each participant’s w value as a function of age/disease group for the 
test sequences.  The dark grey squares within each box shows the group mean.  Older adults and 
PD patients show a wider distribution of w values, relative to young adults.  However, all three 
age/disease groups cluster toward w values closer to 1.  This implies there are not large 
differences between age/disease groups in w values, and that group averages in w values are 
fairly representative of the data.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
